| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/05/2012 | US20120003291 Nanobead releasing medical devices |
| 01/05/2012 | US20120003285 Method for manufacturing capsule series, and related capsule series |
| 01/05/2012 | US20120003282 Pharmaceutical compositions of dextran polymer derivatives |
| 01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
| 01/05/2012 | US20120003218 Antagonists of actriib and uses for increasing red blood cell levels |
| 01/05/2012 | US20120003206 Liquid, aqueous pharmaceutical compositions of factor vii polypeptides |
| 01/05/2012 | US20120003195 In vitro micro-organs, and uses related thereto |
| 01/05/2012 | US20120003181 Novel Retinoid Inducible Factor and Uses Thereof |
| 01/05/2012 | CA2807303A1 Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803660A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/04/2012 | EP2402002A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/04/2012 | EP1339663B1 Naphthalene derivatives |
| 01/04/2012 | CN1896108B Preparation of specific anticoagulation matter and its use |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307869A Aminopyrazine derivative and medicine |
| 01/04/2012 | CN102302727A Traditional Chinese medicine (TCM) for treating iron deficiency anemia |
| 01/04/2012 | CN102302725A Cape jasmine fruit and liquorice hematopoietic pill |
| 01/04/2012 | CN102302709A Preparation method for medicament for treating pediatric disease |
| 01/04/2012 | CN102302693A Method for extracting imperata cylindrical root extract |
| 01/04/2012 | CN102302667A Traditional Chinese medicinal pills for treating iron-deficiency anemia (IDA) |
| 01/04/2012 | CN102302643A Medicine for treating functional uterine bleeding |
| 01/04/2012 | CN102302633A Chinese medicinal composition for treating woman metrorrhagia and preparation method thereof |
| 01/04/2012 | CN102302630A Chinese patent medicine used for increasing leucocytes and enhancing immunity |
| 01/04/2012 | CN102302608A Chinese medicinal composition for treating anemia and preparation method thereof |
| 01/04/2012 | CN102302566A Dampness-eliminating and stasis-removing capsules |
| 01/04/2012 | CN102302539A Method for producing trifolium pratense L. isoflavones |
| 01/04/2012 | CN102302501A Nitrate esters of corticoid compounds useful as diuretics |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302493A Methods to mobilize progenitor/stem cells |
| 01/04/2012 | CN102302479A Application of lycopene in preparation of medicament for treating cerebral ischemia injury |
| 01/04/2012 | CN102302478A Health-care medicine for treating various traumas |
| 01/04/2012 | CN102302474A Orally administered danazol sustained-release capsule and preparation method thereof |
| 01/04/2012 | CN102302473A Matrine magnetic slow-releasing capsule and preparation method |
| 01/04/2012 | CN102302465A Tablet containing clopidogrel hydrogen sulfate and preparation method thereof |
| 01/04/2012 | CN102000140B Novel method for synchronously quantifying matrine and oxymatrine in kuh-seng and preparations of kuh-seng |
| 01/04/2012 | CN101974011B New compound methyl brevicate with medical activity |
| 01/04/2012 | CN101953783B Preparation process of troxerutin injection |
| 01/04/2012 | CN101934046B Semifluid extract of deer foetus and preparation method thereof |
| 01/04/2012 | CN101879255B Medicinal preparation used for treating frostbite and having thrombolysis effect |
| 01/04/2012 | CN101735168B P-sulfamyl benzylidene cyclic ketone compounds, preparation method and application thereof |
| 01/04/2012 | CN101690564B Natto product capable of dissolving thrombus |
| 01/04/2012 | CN101618069B Capsule preparation for treating bruise as well as bleeding and easing pain and preparation method and use thereof |
| 01/04/2012 | CN101475632B Recombinant Ganoderma lucidum immunoregulation protein with antineoplastic function and medicinal preparation thereof |
| 01/04/2012 | CN101428027B Medicament composition for preventing and treating thrombosis |
| 01/04/2012 | CN101306098B Chinese medicinal materials orally taken for treating bronchiectasis hemoptysis |
| 01/04/2012 | CN101181440B Chinese medicine composition for curing hemopathy as well as preparation method and usage thereof |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088827 Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088813 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 01/03/2012 | US8088731 Use of GLP-1 compound for treatment of critically ill patients |
| 01/03/2012 | US8088157 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 01/03/2012 | CA2636432C Peptides and compounds that bind to a thrombopoietin receptor |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/03/2012 | CA2463134C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2420618C Percarboxylated polysaccharides, and a process for their preparation |
| 01/03/2012 | CA2397018C Compounds exhibiting thrombopoietin receptor agonism |
| 01/03/2012 | CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/03/2012 | CA2242414C Anti-cd18 antibodies for use against stroke |
| 01/03/2012 | CA2178482C Thrombopoietin |
| 12/29/2011 | WO2011163533A2 One step removal of selected molecules from body fluid and tissue |
| 12/29/2011 | WO2011163231A2 Combination therapy for the treatment of diabetes |
| 12/29/2011 | WO2011161235A1 Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings |
| 12/29/2011 | WO2011161234A1 Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery |
| 12/29/2011 | WO2011161228A1 Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery |
| 12/29/2011 | WO2011161099A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes |
| 12/29/2011 | WO2011160541A1 Tolvaptan solid dispersion and its preparation method |
| 12/29/2011 | WO2011120040A3 Thrombin inhibiting compositions |
| 12/29/2011 | WO2011094496A3 Trypsin-like serine protease inhibitors, and their preparation and use |
| 12/29/2011 | US20110319858 Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical compositions and the use thereof |
| 12/29/2011 | US20110319496 Process for the preparation of ajoene |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319465 Estrogen receptor modulators and uses thereof |
| 12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 12/29/2011 | US20110319416 Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions |
| 12/29/2011 | US20110319414 Novel triazine derivative and pharmaceutical composition comprising the same |
| 12/29/2011 | US20110319366 Plasma Carboxypeptidase B Inhibitors |
| 12/29/2011 | US20110319350 Glycoside compounds and pharmaceutical compositions thereof |
| 12/29/2011 | US20110319349 Methods for Reducing Platelet Activation and for the Treatment of Thrombotic Events |
| 12/29/2011 | US20110319331 Novel uses of fibrinogen |
| 12/29/2011 | US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury |
| 12/29/2011 | US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 12/29/2011 | US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1 |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | US20110318356 Antibodies Against Tissue Factor Pathway Inhibitor |
| 12/29/2011 | US20110318340 Deglycosylated antibodies |
| 12/29/2011 | US20110318330 Medicinal products for the treatment of blood coagulation disorders |
| 12/29/2011 | CA2840431A1 Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets |
| 12/29/2011 | CA2803688A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes |
| 12/29/2011 | CA2801098A1 Tolvaptan solid dispersion and its preparation method |
| 12/28/2011 | EP2399994A1 Thrombin mutant |
| 12/28/2011 | EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation |
| 12/28/2011 | EP2399914A1 Fused heterocyclic ring compound |
| 12/28/2011 | EP2399593A1 Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile |